Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

651 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    Named Patient Programs

    Named Patient Programs ("NPP") is one of the exceptional importation regimes of pharmaceuticals without marketing authorization ("MA") in Turkey, ...
    TurkeyFood, Drugs, Healthcare, Life Sciences
    Gün + Partners
    Gün + Partners
  • Article

    Pharmacovigilance Obligations Of Marketing Authorisation Holders

    Human medicinal products are launched to market and made available for public use after going through a set of critical clinical trials ...
    TurkeyFood, Drugs, Healthcare, Life Sciences
    Paksoy
    Paksoy
Article

The Decision Of The Health Services Pricing Commission And The Communiqué Amending The Social Security Institution Health Implementation Communiqué Were Published

With the Communiqué on Amendment to the Social Security Authority Health Implementation Communiqué ("Communiqué") and the Decision of the Health...
TurkeyFood, Drugs, Healthcare, Life Sciences
Moroglu Arseven
Moroglu Arseven
  • Article

    The Regulation On Clinical Trials Of New Medicinal Products For Human Use Was Published

    With the relevant regulation published in the Official Gazette dated 27.05.2023 and numbered 32203, the procedures and principles regarding the conduct of clinical trials and the protection of the rights of volunteers...
    TurkeyFood, Drugs, Healthcare, Life Sciences
    Moroglu Arseven
    Moroglu Arseven
  • Article

    The Turkish Medicines And Medical Devices Agency Publishes New Draft Guidelines

    On June 7, 2022, the Turkish Medicines and Medical Devices Agency ("Agency") published the Draft Guidelines on Packaging Information and Legibility of Foods for Special Medical Purposes...
    TurkeyFood, Drugs, Healthcare, Life Sciences
    ELIG Gürkaynak Attorneys-at-Law
    ELIG Gürkaynak Attorneys-at-Law
  • Article

    TITCK Published Guidelines For The Classification Of Diversification Applications And Variation Applications Of Licensed Medicinal Products For Human Use

    Turkish Pharmaceuticals and Medical Devices Agency ("TITCK") published the Guidelines for the Classification of Diversification Applications and Variation Applications ("Guidelines") on 14 April 2022.
    TurkeyFood, Drugs, Healthcare, Life Sciences
    Moroglu Arseven
    Moroglu Arseven
  • Article

    Turkish Healthcare Agency Publishes Draft Regulation On Licensing Of Homeopathic Medical Products

    The Agency has invited concerned parties to send their comments within the table format provided through the announcement through the specified e-mail address, until September 20, 2021.
    TurkeyFood, Drugs, Healthcare, Life Sciences
    ELIG Gürkaynak Attorneys-at-Law
    ELIG Gürkaynak Attorneys-at-Law
  • Article

    Türkiye'de İlaç, Tıbbi Cihaz Ve Sağlık Hukuku Önemli Gelişmeler Ve Öngörüler - 2021

    Bu yılki raporumuzda, Türkiye'de ilaç, tıbbi cihaz ve sağlık hukukunda en tartışılan ve önemli görüğümüz konuları ana hatlarıyla ele alıyoruz.
    TurkeyFood, Drugs, Healthcare, Life Sciences
    Gün + Partners
    Gün + Partners
  • Article

    TİTCK Medical Device Regulations Harmonised With The European Union Legislation

    Amendments to align the regulations with existing EU standards on medical devices and in vitro diagnostic devices, ensuring their applicability in Türkiye, were published on August 17, 2024.
    TurkeyFood, Drugs, Healthcare, Life Sciences
    CBC Law
    CBC Law
  • Article

    TİTCK Ruhsatlı Beşerî Tıbbi Ürünlerin Çeşitleme Başvuruları Ile Varyasyon Başvurularının Sınıflandırılmasına Dair Kılavuz Yayımladı

    Türkiye İlaç ve Tıbbi Cihaz Kurumu ("TİTCK"), Çeşitleme Başvuruları ile Varyasyon Başvurularının Sınıflandırılmasına Dair Kılavuz'u ("Kılavuz") 14 Nisan 2022 tarihinde yayımladı.
    TurkeyFood, Drugs, Healthcare, Life Sciences
    Moroglu Arseven
    Moroglu Arseven
  • Article

    New Exemption For Procurements Of The State Supply Office

    With the Law No. 7491 published in the Official Gazette dated 28 December 2023, an additional article 12 was added to the Public Procurement Law (the "Law").
    TurkeyGovernment, Public Sector
    Gün + Partners
    Gün + Partners
  • Article

    A Milestone Decision On The Patentability Of Second Medical Use Claims

    As per the EPC definition, a substance or composition that is already known to have been used in a "first medical use" may still be patentable for any second or further use...
    TurkeyIntellectual Property
    Gün + Partners
    Gün + Partners
  • Article

    Navigating Türkiye's Legal Landscape On Parallel Imports And Grey Market Goods

    Parallel imports and grey market goods (ie, genuine products that have been imported into a country without the trademark owner's consent, after being legitimately placed on the market elsewhere]...
    TurkeyIntellectual Property
    Gün + Partners
    Gün + Partners
  • Article

    Seeking Information On Pending MA Applications Is Lawful According To Administrative Court

    As per article 9 of the Regulation on Licencing, which regulates "Abridged Application", if a pharmaceutical has been licenced before, it is not necessary to repeat the tests and research and the data of these tests...
    TurkeyIntellectual Property
    Gün + Partners
    Gün + Partners
  • Article

    Supply Of Pharmaceutical Products From Abroad And Patent Rights

    The supply of pharmaceutical products to Turkey via the named patient programme (the "NPP") is one of the exceptional importation regimes for pharmaceutical products.
    TurkeyIntellectual Property
    Gün + Partners
    Gün + Partners
  • Article

    Turkish Medicine And Medical Devices Agency Updates Guidelines For Scientific Meetings And Educational Activities

    The Turkish Medicine and Medical Devices Agency ("Agency") of the Ministry of Health issued an announcement on April 27, 2020 updating the Guidelines for Scientific Meetings and Educational...
    TurkeyFood, Drugs, Healthcare, Life Sciences
    ELIG Gürkaynak Attorneys-at-Law
    ELIG Gürkaynak Attorneys-at-Law
  • Article

    REGIONAL COURT OF APPEALS: The Decision Of The Turkish Medicines And Medical Devices Agency Of Refusal Of The Applications Of The Original Medicine Owners To Obtain Information On Reference Product Is Unlawful

    As per article 9 of the Regulation on Authorization, which regulates "Abridged Application", if a pharmaceutical has been authorized before, it is not necessary to repeat the tests and research, and the data of these tests doesn't have to be submitted for authorizing again.
    TurkeyIntellectual Property
    Gün + Partners
    Gün + Partners
  • Article

    EU Pharmaceutical Package - EU Pharmaceutical Legislative Reform And Its Impact On Türkiye

    On 26 April 2023, the European Commission (the "Commission") adopted a proposal for a new Directive and Regulation (the "Proposal") which revise and replace...
    European UnionIntellectual Property
    Gün + Partners
    Gün + Partners
  • Article

    Turkey’s Pharmaceutical Sector Inquiry

    The pharmaceutical sector has long attracted the scrutiny of antitrust authorities in many jurisdictions, mainly over major patent holders’ alleged abuse of market power.
    TurkeyAntitrust/Competition Law
    Hergüner Bilgen Üçer Attorney Partnership
    Hergüner Bilgen Üçer Attorney Partnership
  • Article

    Two-minute Recap Of Competition Law Matters Around The Globe – October 2022

    In November 2021, the CMA found that Meta's acquisition of Giphy could harm social media users and advertisers and ordered Meta to sell Giphy. After Meta's appeal, the Competition Appeal Tribunal noted that the..
    TurkeyAntitrust/Competition Law
    Gen Temizer Erdogan Girgin Attorney Partnership
    Gen Temizer Erdogan Girgin Attorney Partnership
  • Showing 201–220 of 651 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics